Details for Patent: 5,418,226
✉ Email this page to a colleague
Summary for Patent: 5,418,226
Title: | Monoquaternary 2,16-bispiperidinylandrostane derivatives |
Abstract: | Monoquaternary 2,16-bispiperidinylandrostane neuromuscular blocking derivatives having the formula: ##STR1## wherein R.sub.1 is ethyl; R.sub.2 is methyl or allyl; and X.sup.- is a pharmaceutically acceptable anion; or pharmaceutically acceptable salts thereof. |
Inventor(s): | Sleigh; Thomas (Wishaw, GB6), Carlyle; Ian C. (Hamilton, GB6), Muir; Alan W. (Ravenstruther, GB6) |
Assignee: | Akzo N.V. (Arnhem, NL) |
Application Number: | 08/048,539 |
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent 5,418,226
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,418,226
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
92303612 | Apr 22, 1992 |
International Family Members for US Patent 5,418,226
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 145918 | ⤷ Try a Trial | |||
Australia | 3703093 | ⤷ Try a Trial | |||
Australia | 662277 | ⤷ Try a Trial | |||
Canada | 2094457 | ⤷ Try a Trial | |||
Czech Republic | 286728 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |